Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
dpa

HOME > dpa

Innovation for cancer researchers and patients in eastern Germany

June 22, 2022


Abstract : Cancer patients can be treated with a new magnetic resonance linear accelerator (MR-Linac) at the National Center for Radiation Research in Oncology (OncoRay) in Dresden in the eastern German state of Saxony.

Cancer patients can be treated with a new magnetic resonance linear accelerator (MR-Linac) at the National Center for Radiation Research in Oncology (OncoRay) in Dresden in the eastern German state of Saxony. This would raise cancer treatment and research at the center to a new level and keep it at the cutting edge nationally and internationally, said Saxony's Science Minister Sebastian Gemkow at the inauguration. The device makes it possible to provide real-time images during radiation treatment for the first time. The State of Saxony provided almost nine million euros in funding for the investment, which included EU funds.

Saxony's state capital of Dresden is the first location in eastern Germany to be equipped with the accelerator and the fifth nationwide, joining Heidelberg and Tübingen (Baden-Württemberg), Munich (Bavaria) and Trier (Rhineland-Palatinate).

The 16-ton large-scale piece of equipment combines the technologies of magnetic resonance and a linear particle accelerator. This makes it possible to image the position of the tumor and its surrounding organs with high resolution and in real time during irradiation, allowing the smallest tumors in regions of the body that are difficult to access to be identified and safely irradiated, while at the same time not affecting healthy tissue. This will make treatment even more effective in the future, "allowing the lives of more people to be improved or saved," Gemkow said.

Notice: No person, organization and/or company shall disseminate or broadcast the above article on Xinhua Silk Road website without prior permission by Xinhua Silk Road.

Scan the QR code and push it to your mobile phone

Keyword: cancer

Reading:

China's self-developed cancer drug approved in 50 markets

Chinese pharma to develop global ESG strategy, promote health equity worldwide

BioNTech expects Omicron variant vaccines results within weeks

China-developed minimally invasive surgical technique - Natural Orifice Specimen Extraction Surgery (NOSES) promoted to the world

New Horizon Health partners with Prenetics on ColoClear

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial